搜尋結果
Could this advance in radionuclide therapy help late-stage cancer patients?
South China Morning Post· 2 小時前Peking University, whose researchers led the study along with researchers from Peking Union ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 18 小時前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 18 小時前There's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks ...
U.S. FDA advisers back approval for Guardant's blood-based cancer test
Reuters· 12 小時前, opens new tab blood test to detect a cancer that begins in the colon or rectum. The panel ...
細胞治療 - 香港經濟日報 - 報章 - 副刊
經濟日報· 17 小時前「細胞治療」這名詞在癌症病人圈子迴響多年,甚麼NK cell(Natural killer)、Dendritic cell和Stem cell治療,愈貴愈好,更有專人安排到日本或台灣才夠吸引, ...
創勝集團於ASCO 2024首次公佈Osemitamab (TST001)三聯療法一線治療胃或胃食管結合部腺癌令人鼓舞的II ...
am730· 10 小時前II期臨床結果顯示,CLDN18.2高/中表達,包括PD-L1 CPS<5患者的中位無進展生存期(mPFS)為12.6個月。 美國新澤西州普林斯頓和中國蘇州2024年5月24日 /美 ...